Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Neurofeedback is a kind of biofeedback usually teaches self-control of brain functions to subjects by measuring brain waves and providing a feedback signal. This devices are majorly used as an effective treatment for depression, anxiety, stress, affective disorders, obsessive?compulsive disorder, and fibromyalgia. The changing lifestyle and increasing stress among is key factor for the growth of the market. These next generation neurofeedback devices is widely for anxiety, attention deficit hyperactivity disorder (adhd), depression, drug addiction, epilepsy, insomnia, schizophrenia further increasing support, especially due to EEG connectivity for the patient treatment. Various neurofeedback treatment protocols i.e. alpha, beta, alpha/theta, delta, gamma, and theta and different eeg electrode placements i.e. standard recording channels in the frontal, temporal, central, and occipital lobes helps for the patients treatment. The next-generation neurofeedback devices market is expected to significant growth during the forecast period.
The key factor driving for the growth of next-generation neurofeedback devices market is growing Burden of brain dysfunctions which heavily impact individuals and their families. For instance, the brain disorders account for roughly a third of total years lost to death and disability from all diseases more than combined number for cancer and cardiovascular disease. Further the growing number of people living with certain brain disorders is expected to increase over the coming decades. Besides increasing technological advances towards brain monitoring is fueling the demand for next-generation neurofeedback devices market
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the next-generation neurofeedback devices market. In addition, complete analysis of changes on the next-generation neurofeedback devices market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. COVID-19 impact was moderate on the next-generation neurofeedback devices market as the pandemic had led to stop the major production and supply for months
The next-generation neurofeedback devices market is segmented based on by product type, application, end user and geography
The next-generation neurofeedback devices market is available in different types including brand name neurofeedback systems and 3d neurofeedback systems. Neurofeedback systems is major used owing to focus on training patients to increase certain brainwaves whilst inhibiting others, to promote optimal brain regulation. The various components extracted and fed to subjects using online feedback loop in the form of audio, video or their combination is further driving the growth of market.
The next-generation neurofeedback devices market finds application in anxiety, attention deficit hyperactivity disorder (adhd), depression, drug addiction, epilepsy, insomnia, schizophrenia. Anxiety followed by schizophrenia is expected to lead in application owing to increasing patients related to this disorder thereby fueling the demand for next-generation neurofeedback devices market. The device helps to improve schizophrenia patients significantly and at the end of treatment the patients do not meet the diagnostic criteria of negative symptom any longer further fueling the demand for next-generation neurofeedback devices market. Depression is however expected to growth at significant rate during forecast period.
The next-generation neurofeedback devices market has end user in ambulatory surgical centers, clinics, hospitals, physician offices. Hospital is expected to lead in the next-generation neurofeedback devices owing to increasing patient’s inflow related to different disorders like depression, anxiety and others. In addition, the advanced device and doctors in hospital acts as key factor for the growth of market. Whereas Clinics is expected to growth at a significant rate during the forecast period.
Geographically the global next-generation neurofeedback devices market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW). North America is anticipated to lead in the next-generation neurofeedback devices market accounting the major market share in next-generation neurofeedback devices. The growth is attributed to presence of key companies in the region and increasing acquisition and collaboration in the region. On the other hand Europe is expected to witness significant growth during forecast period owing to developing healthcare infrastructure and increasing patients in the region will further fuel the demand for next-generation neurofeedback devices market. Besides Asia Pacific is expected grow at significant rate during the forecast period due to increasing market in countries like China, Japan and Latin American countries. The increasing patients and rising awareness in Asia Pacific had led to the demand of next-generation neurofeedback devices market.
The key players in next-generation neurofeedback devices market are ANT Neuro, Brain State Technologies, LLC, BrainBit, Brainmaster Technologies, Inc., EEGinfo, LOOXID LABS, Neurable, Neurofeedbackuk, Neurogen Ltd and Neurotech International Ltd (Mente) among others.
May 2020: Naxo labs had a cheap and useful tool and neurofeedback system for professionals in the fields of Engineering and Information Technology, Neuroscience, and Medicine. Using this technology, you can save time with automatic blink and artifact detection and display in real-time brain wave frequencies per channel or by average. The data captured can be downloaded for further analysis with tools like MATLAB, Brainstorm or EEG Lab. The device can be connected from a PC, a MAC or a tablet with Bluetooth.
June 2018: NeuroPace Inc. had announced the launch of its Next Gen RNS System for the treatment of refractory epilepsy. The RNS System is a type of brain-computer interface that treats seizures by continuously monitoring brain waves, recognizing each patient’s unique “seizure onset fingerprint,” and automatically responding with imperceptible electrical pulses before seizures occur.
The report analyses the next-generation neurofeedback devices market based on by product type, application, end user and geography. The next-generation neurofeedback devices market is available in different types including brand name neurofeedback systems and 3d neurofeedback systems. The next-generation neurofeedback devices market finds application in anxiety, attention deficit hyperactivity disorder (adhd), depression, drug addiction, epilepsy, insomnia, schizophrenia. The next-generation neurofeedback devices market has end user in ambulatory surgical centers, clinics, hospitals, physician offices. Geographically the global next-generation neurofeedback devices market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW).
The key players in next-generation neurofeedback devices market are ANT Neuro, Brain State Technologies, LLC, BrainBit, Brainmaster Technologies, Inc., EEGinfo, LOOXID LABS, Neurable, Neurofeedbackuk, Neurogen Ltd and Neurotech International Ltd (Mente) among others.
Why to buy this report:
